132 related articles for article (PubMed ID: 2106534)
1. Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
Kahn EM; Schulz SC; Perel JM; Alexander JE
J Clin Psychopharmacol; 1990 Feb; 10(1):54-7. PubMed ID: 2106534
[TBL] [Abstract][Full Text] [Related]
2. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive carbamazepine or lithium carbonate in therapy-resistant chronic schizophrenia.
Simhandl C; Meszaros K; Denk E; Thau K; Topitz A
Can J Psychiatry; 1996 Jun; 41(5):317. PubMed ID: 8793154
[No Abstract] [Full Text] [Related]
4. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
[TBL] [Abstract][Full Text] [Related]
5. [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].
Llorca PM; Wolf MA; Lançon C; Bougerol T
Encephale; 1993; 19(5):565-71. PubMed ID: 8306925
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Klein E; Bental E; Lerer B; Belmaker RH
Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
[TBL] [Abstract][Full Text] [Related]
7. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.
Wilson WH
Psychopharmacology (Berl); 1993; 111(3):359-66. PubMed ID: 7870975
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide.
Raptis C; Garcia-Borreguero D; Weber MM; Dose M; Bremer D; Emrich HM
Acta Psychiatr Scand; 1990 Feb; 81(2):162-7. PubMed ID: 2183543
[TBL] [Abstract][Full Text] [Related]
9. Lithium combined with haloperidol in schizophrenic patients.
Lerner Y; Mintzer Y; Schestatzky M
Br J Psychiatry; 1988 Sep; 153():359-62. PubMed ID: 3150693
[TBL] [Abstract][Full Text] [Related]
10. Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study.
Biederman J; Lerner Y; Belmaker RH
Arch Gen Psychiatry; 1979 Mar; 36(3):327-33. PubMed ID: 369472
[TBL] [Abstract][Full Text] [Related]
11. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
[TBL] [Abstract][Full Text] [Related]
12. Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.
Maas JW; Miller AL; Tekell JL; Funderburg L; Silva JA; True J; Velligan D; Berman N; Bowden CL
J Clin Psychopharmacol; 1995 Oct; 15(5):361-4. PubMed ID: 8830068
[TBL] [Abstract][Full Text] [Related]
13. Effects of carbamazepine on plasma haloperidol levels.
Jann MW; Ereshefsky L; Saklad SR; Seidel DR; Davis CM; Burch NR; Bowden CL
J Clin Psychopharmacol; 1985 Apr; 5(2):106-9. PubMed ID: 3988968
[TBL] [Abstract][Full Text] [Related]
14. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S
J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118
[TBL] [Abstract][Full Text] [Related]
15. The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
Hirschowitz J; Hitzemann R; Piscani K; Burr G; Frecska E; Culliton D; Mann M; Curtis C
Schizophr Res; 1997 Jan; 23(1):31-43. PubMed ID: 9050126
[TBL] [Abstract][Full Text] [Related]
16. Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics.
Gattaz WF; Rost W; Hübner CK; Bauer K
Biol Psychiatry; 1989 Feb; 25(3):247-55. PubMed ID: 2643996
[TBL] [Abstract][Full Text] [Related]
17. [Carbamazepine: an effective adjuvant treatment in the schizophrenias].
Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(4):245-50. PubMed ID: 2678932
[TBL] [Abstract][Full Text] [Related]
18. A double-blind trial of carbamazepine in negative symptom schizophrenia.
Nachshoni T; Levin Y; Levy A; Kritz A; Neumann M
Biol Psychiatry; 1994 Jan; 35(1):22-6. PubMed ID: 7909450
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol plasma levels and acute clinical change in schizophrenia.
Coryell W; Kelly M; Perry PJ; Miller DD
J Clin Psychopharmacol; 1990 Dec; 10(6):397-402. PubMed ID: 2286709
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine as an adjunct of antipsychotic therapy.
Dose M; Apelt S; Emrich HM
Psychiatry Res; 1987 Dec; 22(4):303-10. PubMed ID: 3324137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
